(Q44064662)

29 November 2017

title

Are infertility treatments a potential risk factor for cancer development? Perspective of 30 years of follow-up (English)

1 reference

29 November 2017

0 references

1

Liat Lerner-Geva

0 references

author name string

Liat Lerner-Geva

1

1 reference

29 November 2017

Jaron Rabinovici

2

1 reference

29 November 2017

Liraz Olmer

3

1 reference

29 November 2017

Tzvia Blumstein

4

1 reference

29 November 2017

Shlomo Mashiach

5

1 reference

29 November 2017

Bruno Lunenfeld

6

1 reference

29 November 2017

publication date

5 April 2012

1 reference

Gynecological Endocrinology

29 November 2017

published in

1 reference

29 November 2017

volume

28

1 reference

29 November 2017

issue

10

1 reference

29 November 2017

page(s)

809-814

1 reference

Long-term effects of ovulation-stimulating drugs on cancer risk

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Infertility as a cancer risk factor - a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Cancer risk associated with subfertility and ovulation induction: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

The link between female infertility and cancer: epidemiology and possible aetiologies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Cancer incidence in a cohort of infertile women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Incessant ovulation--a factor in ovarian neoplasia?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative Ovarian Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Breast and ovarian cancer incidence after infertility and in vitro fertilisation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Risk of cancer after use of fertility drugs with in-vitro fertilisation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Cancer incidence following treatment for infertility at a clinic in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Cancer incidence in a cohort of infertile women who underwent in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Cancer risk after exposure to treatments for ovulation induction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Use of fertility drugs and risk of ovarian cancer: Danish Population Based Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Assisted reproductive technology and the incidence of ovarian cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in israel

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Focus on breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Fertility drugs and the risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Development Women’s Contraceptive and Reproductive Experiences Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Breast cancer incidence in women with a history of progesterone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Breast cancer risk associated with ovulation-stimulating drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

A prospective study of infertility due to ovulatory disorders, ovulation induction, and incidence of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Breast cancer incidence after hormonal infertility treatment in Sweden: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Fertility drugs and the risk of breast cancer: a meta-analysis and review.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Uterine cancer after use of clomiphene citrate to induce ovulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Ovulation induction and risk of endometrial cancer: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Ovulation induction and cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Treatment for infertility and risk of invasive epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Use of fertility drugs and risk of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Fertility treatment and risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Infertility, fertility drugs, and invasive ovarian cancer: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Infertility, Fertility Drugs, and Ovarian Cancer: A Pooled Analysis of Case-Control Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

Infertility: Fertility drugs and risk of epithelial ovarian cancer in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2012.671391

10.3109/09513590.2012.671391

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference